« Previous
Next »
Titles
- Formal meetings between FDA and ANDA applicants of complex products under GDUFA: guidance for industry1
- Format and content of a REMS document: guidance for industry1
- Fostering medical device improvement: FDA activities and engagement with the voluntary improvement program : guidance for industry and Food and Drug Administration staff1
- Four states reviewed received increased Medicaid COVID-19 funding even though they terminated some enrollees’ coverage for unallowable or potentially unallowable reasons1